Assertio Holdings, Inc. 8-K

What Happened
Assertio Holdings, Inc. (ASRT) announced on April 29, 2026 that, in connection with the previously disclosed Agreement and Plan of Merger dated April 8, 2026 among Assertio, Garda Therapeutics, Inc. and Audi Merger Sub, Inc., the companies mutually agreed to extend the deadline to commence the previously announced tender offer for all outstanding Assertio common stock to May 4, 2026. The company issued a press release dated April 29, 2026 (filed as Exhibit 99.1 to the Form 8-K) disclosing the extension.

Key Details

• Extension date: the tender offer commencement deadline was extended to May 4, 2026.
• Merger context: extension is tied to the Agreement and Plan of Merger dated April 8, 2026 among Assertio, Garda Therapeutics, Inc., and Audi Merger Sub, Inc.
• Disclosure: press release issued April 29, 2026 and attached as Exhibit 99.1 to the Form 8-K.

Why It Matters
This change alters the timing for shareholders considering the tender offer and could affect short-term trading or decision timelines. The filing does not disclose any changes to the economic terms of the merger; it only reports the mutual agreement to extend the start date. Investors should review the April 29 press release and monitor subsequent SEC filings for any further updates on the merger timetable or material terms.